Goldman Sachs
FMTX

Goldman Sachs’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Goldman Sachs’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-321,553
Closed -$6.42M – 6634
2022
Q3 		$6.42M Buy
321,553
+135,211
+73% +$1.78M ﹤0.01% 2916
2022
Q2 		$1.28M Sell
186,342
-72,394
-28% -$508K ﹤0.01% 4422
2022
Q1 		$2.41M Sell
258,736
-14,117
-5% -$150K ﹤0.01% 4096
2021
Q4 		$3.88M Buy
272,853
+78,308
+40% +$1.35M ﹤0.01% 3663
2021
Q3 		$4.51M Buy
194,545
+30,810
+19% +$728K ﹤0.01% 3449
2021
Q2 		$4.08M Sell
163,735
-17,151
-9% -$461K ﹤0.01% 3527
2021
Q1 		$5.07M Buy
180,886
+60,188
+50% +$2.17M ﹤0.01% 3123
2020
Q4 		$4.21M Buy
+120,698
New +$5.25M ﹤0.01% 3133
2020
Q3 		– Sell
-96,597
Closed -$4.49M – 5612
2020
Q2 		$4.49M Buy
+96,597
New +$4.19M ﹤0.01% 2870

Goldman Sachs's FMTX Position: Q4 2022 in Review

Goldman Sachs sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 321,553 shares — an estimated $6.42M sold.

Goldman Sachs first reported a position in FMTX in Q2 2020 and held it in 9 quarters. The position peaked at $6.42M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Goldman Sachs reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Goldman Sachs sold 321,553 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $6.42M.
  • Goldman Sachs first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
  • Goldman Sachs's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $6.42M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.